The study, published in JAMA Internal Medicine, cited data from the telemedicine abortion pill provider Aid Access. It found that requests to the organization spiked when the Supreme Court’s Dobbs ruling of 2022 was leaked. The study, published in JAMA Internal Medicine and citing data from the telemedicine provider of abortion pills Aid Access, found that requests to the organization spiked when a Supreme Court decision in 2022, Dobbs, was leaked.
According to research released on Tuesday, requests for abortion medication among women who are not female increased in the days following the leak of the Supreme Court’s 2022 Dobbs decision. The study, which was published in JAMA Internal Medicine, found requests to the organization spiked in May 2022 when a… cited data from the telemedicine abortion pill provider Aid Access. According to research released on Tuesday, non-pregnant women’s requests for abortion medication increased significantly in the days following the leak of the Dobbs decision by the Supreme Court in 2022. According to the study, which was published in JAMA Internal Medicine, requests to Aid Access increased significantly in May 2022 as a result of data from the telemedicine abortion pill provider.
The study, published in JAMA Internal Medicine, cited data from the telemedicine abortion pill provider Aid Access. It found that requests to the organization spiked when the Supreme Court’s Dobbs ruling of 2022 was leaked. The study, published in JAMA Internal Medicine and citing data from the telemedicine provider of abortion pills Aid Access, found that requests to the organization spiked when a Supreme Court decision in 2022, Dobbs, was leaked.
